A REVIEW ON FAST DISSOLVING SUBLINGUAL FILMS FOR ...
Transcript of A REVIEW ON FAST DISSOLVING SUBLINGUAL FILMS FOR ...
www.wjpps.com Vol 4, Issue 03, 2015.
342
Varsha et al. World Journal of Pharmacy and Pharmaceutical Sciences
A REVIEW ON FAST DISSOLVING SUBLINGUAL FILMS FOR
SYSTEMIC DRUG DELIVERY
Varsha S. Nair1*,
R B. Saudagar2,
S. B. Gondkar3
1*
Department of Quality Assurance Techniques, R. G. Sapkal College of Pharmacy, Anjaneri,
Nashik-422213,Maharashtra, India.
2Department of Pharmaceutical chemistry. R. G. Sapkal College of Pharmacy, Anjaneri,
Nashik-422213, Maharashtra, India.
3Department of Pharmaceutics, R. G. Sapkal College of Pharmacy, Anjaneri,
Nashik-422213, Maharashtra, India.
ABSTRACT
Orally fast dissolving films are an emerging technology with fast onset
of activity and improved patient compliance. It enhances the viability
of API's and gives better medication use. These formulations are
suitable for cold, allergy rhinitis, asthma attacks, CNS issue where fast
onset of activity is needed for quicker help. The sublingual course of
medication organization is extremely compelling following the
medication retained through the sublingual veins by passes hepatic first
pass metabolic procedure and also gives a better bioavailability. The
present article outlines the definition viewpoints, manufacturing
methods like solvent casting method, evaluation parameters and
applications of fast dissolving films by sublingual route.
KEYWORDS: Sublingual delivery, Improved bioavailability, Solvent casting method.
INTRODUCTION
The Fast Dissolving Drug Delivery Systems was a headway that started to be in the early
1970's and combats over the utilization of the tablets, syrups, capsules which are the other
oral drug delivery system. Fast Dissolving Drug Delivery Systems serves as a real benefit
over the conventional dosage forms since the drugs gets quickly disintegrated & dissolves in
the salivation without the utilization of water.
WWOORRLLDD JJOOUURRNNAALL OOFF PPHHAARRMMAACCYY AANNDD PPHHAARRMMAACCEEUUTTIICCAALL SSCCIIEENNCCEESS
SSJJIIFF IImmppaacctt FFaaccttoorr 22..778866
VVoolluummee 44,, IIssssuuee 0033,, 334422--336611.. RReevviieeww AArrttiiccllee IISSSSNN 2278 – 4357
Article Received on
24 Dec 2014,
Revised on 19 Jan 2015,
Accepted on 12 Feb 2015
*Correspondence for
Author
Varsha S. Nair
Department of Quality
Assurance Techniques, R.
G. Sapkal College of
Pharmacy, Anjaneri,
Nashik-422213,
Maharashtra, India.
www.wjpps.com Vol 4, Issue 03, 2015.
343
Varsha et al. World Journal of Pharmacy and Pharmaceutical Sciences
The most well known oral solid dosage forms are tablets and containers. Numerous patients
find it hard to swallow tablets and hard gelatin capsules especially pediatric and geriatric
patients and do not take their medicines as prescribed.
Trouble in swallowing or dysphagia is seen to afflict almost 35% of the overall population.
At times, for example, motion sickness, sudden episode of unfavorably susceptible assault or
hacking, dread of gagging and an inaccessibility of water, the gulping of tablet alternately
containers may get to be troublesome. To overcome these troubles, a few fast dissolving
medication drug delivery system have been created. [1,2]
Orally fast-dissolving film is new drug delivery system for the oral delivery of the drugs. It
was developed on the basis of technology of the transdermal patch. The delivery system
consists of a very thin oral strip, which is simply placed on the patient’s tongue or any oral
mucosal tissue, instantly wet by saliva the film rapidly hydrates and adheres onto the site of
application. It then rapidly disintegrates and dissolves to release the medication for
oromucosal and intragastric absorption. Technology Catalysts forecasts the market for drug
products in oral thin film formulations was valued of $500 million in 2007 and could reach
$2 billion in 2012. Based on upward global growth trends of the past decade, the fast
dissolving dosage market could produce revenues of $13 billion by 2015.
Fast dissolving film is prepared using hydrophilic polymers that rapidly dissolves or
disintegrates in the mouth within few seconds and eliminates the fear of chocking as an
alternative to fast dissolving tablets. [3, 4]
Most fast dissolving films are accepting taste masked active ingredients which are swallowed
by the saliva of patients along with the soluble and insoluble ingredients.
This fast dissolving drug delivery system (FDDS) is fitted for the drugs which undergo high
first pass metabolism and is used for improving bioavailability with reducing dosing
frequency to mouth plasma peak levels, which in turn minimize adverse/side effects and
aswell accomplish it cost effective. [5]
Drug delivery by per-oral administering appear some problems such as hepatic first pass
metabolism and enzymatic degradation within the GI tract.[6]
For certain class of drugs, these
problems can be overcome by their administration through sublingual mucosa.
www.wjpps.com Vol 4, Issue 03, 2015.
344
Varsha et al. World Journal of Pharmacy and Pharmaceutical Sciences
OVERVIEW OF THE ORAL CAVITY [7]
The oral mucosa is made out of a outermost layer of stratified squamous epithelium. Beneath
this lies a basement membrane, a lamina propria followed by the submucosa as the innermost
layer. The oral mucosa in general is intermediate between that of the epidermis and intestinal
mucosa in terms of permeability. It is assessed that the permeability of the buccal mucosa is
4-4000 times greater than that of the skin. There are extensive differences in permeability
between different regions of the oral cavity because of the various structures and functions of
the different oral cavity.
Fig. 1: Figure of sublingual gland
Sublingual glands [8]
Salivary glands are available in the floor of the mouth underneath the tongue. They are also
known as sublingual glands. They produce mucin in turn produces saliva. The inner area of
the mouth stays lubricated due to production of the saliva by the glands, which is necessary
Fig. 1: Diagram of the sublingual gland
Fig. 2: Figure of Oral Mucosa
www.wjpps.com Vol 4, Issue 03, 2015.
345
Varsha et al. World Journal of Pharmacy and Pharmaceutical Sciences
for chewing and food swallowing. The fluid which is produced by the glands gets blend with
the food, so the food gets easily chewed. Due to low secretion of the saliva it can create
problem in swallowing the food and potential for food lodge in the throat increases. The
absorption is transfer of the drug from its site of administration into systemic circulation, so it
can be said that absorption is directly proportional layer thickness. The absorption of the drug
is like Sublingual > Buccal > Gingival >Palatal. Due to high permeability and rich blood
supply, the sublingual route can deliver fast onset of action so the drug with short delivery
period can be delivered and dose regimen is regulars. The drug gets diluted in the saliva and
from there the drug is adsorbed across the oral cavity.
Sublingual absorption
The absorption capability of the buccal mucosa is impacted by the lipid solubility and
therefore the permeability of the solution (osmosis), the ionization (pH), and the molecular
weight of the substances. For example, absorption of few drugs via the buccal mucosa is
shown to increase when carrier pH is lowering (more acidic) and decrease with a lowering of
pH (more alkaline) 7.9.[9,10]
The cells of the oral epithelium and epidermis are additionally fit for retaining by endocytosis
(the uptake of particles by a cell as though by hollowly wrapping itself around it. These
inundated particles are generally excessively vast to diffuse through its divider).It is
impossible that this mechanism is utililized over the whole stratified epithelium. It is also
unlikely that active transport processes operate within the oral mucosa. However, it is
accepted that acidic stimulation and uptake into the circulatory system. [11]
Special Features [12, 13]
Thin elegant film
Various sizes and shapes
Unobstructive
Mucoadhesion
Fast disintegration
Quick dissolving
Rapid release
www.wjpps.com Vol 4, Issue 03, 2015.
346
Varsha et al. World Journal of Pharmacy and Pharmaceutical Sciences
FACTORS AFFECTING THE SUBLINGUAL ABSORPTION [14]
Solubility in Salivary Secretion
In addition to high lipid solubility, the drug should be soluble in aqueous buccal fluids i.e.
biphasic solubility of drug is all-important for absorption.
Binding to Oral Mucosa
Systemic availability of drugs that bind to oral mucosa is poor.
pH and pKa of The Saliva
As the mean pH of the saliva is 6.0, this pH favors the absorption of drugs which remain
unionized. Also, the absorption of the drugs through the oral mucosa occurs if the pKa is
greater than 2 for an acid and less than 10 for a base.
Lipophilicity of Drug
For a drug to be absorbed absolutely through sublingual route, the drug must have slightly
higher lipid solubility than that required for GI absorption is all-important for passive
permeation.
Thickness of Oral Epithelium
As the thickness of sublingual epithelium is 100‐200 μm which is less as compared to buccal
thickness. So the absorption of drugs is faster due to thinner epithelium and aswell the
immersion of drug in smaller volume of saliva.
CHARACTERISTICS OF AN IDEAL ORALLY SOLUBLE FILM DRUG DELIVERY
SYSTEM
1. Do not require water to swallow and should dissolve or disintegrate in the mouth within a
few seconds.
2. Compatible with taste masking and added excipients.[15]
3. They possess pleasant mouth feel.[16]
4. Leave minimal or no residue in the mouth after oral administration.
5. They can bears the rigors of the manufacturing process and post manufacturing
handling.[17]
6. Resistant to environmental conditions such as humidity and temperature.[17]
7. They are adustable and amenable to the absolute processing and packaging machinery.
8. Processing and packaging of strips/ films can be done at low amount prices.[17]
www.wjpps.com Vol 4, Issue 03, 2015.
347
Varsha et al. World Journal of Pharmacy and Pharmaceutical Sciences
ADVANTAGES OF THIN FILMS [18]
1. Thin film is more stable, durable and quick dissolving than other conventional dosage
form.
2. Thin film enables to improve dosage accuracy relative to liquid formulations, since every
strip is manufactured in such a way that it contains a absolute amount of the drug.
3. Buccal films not only ensure more accurate administration of drug, but also can improve
compliance due to the intuitive nature of the dosage form and its inherent ease of
administration.
4. Buccal films has the ability to dissolve rapidly without the need for water, which provides
an alternate way to the patients to swallow and to patients suffering from nausea, such as
those patients receiving chemotherapy.
5. Permits continuous drug administration and the use of drugs with a short biological half-
life.
6. Accessibility of larger surface area that leads to quickly disintegrate and dissolution in
the oral cavity within seconds.
7. The large surface area available in the film dosage form allows rapid wetting by saliva
then quickly disintegrates and dissolve and absorbed directly and can enter the systemic
circulation without undergoing first-pass hepatic metabolism and on increase the
bioavailability.
8. The first pass effect can be avoided, so a reduction in the dose which can prompt to
decrease in side effects associated with the molecule.
9. It also avoids the risk and inconveniences of intravenous therapy.
10. Sublingual film delivers a convenient, quick-dissolving therapeutic dose contained within
an abuse-deterrent film matrix that cannot be crushed or injected by patients, and rapidly
absorbs under the tongue to ensure compliance.
DISADVANTAGES OF THIN FILMS
1. High doses cannot be incorporated.
2. Dose uniformity is a technical challenge.
3. These films are moisture sensitive and expensive packing of oral film is required.
4. Limitations: Most bitter drugs should be avoided or taste masking is required.
Proteinaceous drugs should be avoided if used then co-administration of enzyme
inhibitors such as aprotinin bestatin, puromicin and bile salts required for the inhibition of
proteolytic enzymes present in saliva.
www.wjpps.com Vol 4, Issue 03, 2015.
348
Varsha et al. World Journal of Pharmacy and Pharmaceutical Sciences
FORMULATION DEVELOPMENT
Table 1: General Composition of Fast dissolving films
Sr. No. Category Concentration (%)
1. Drug 1-25%
2. Hydrophilic Polymer 40-50%
3. Plasticizer 0-20%
4. Colors, Flavors, Fillers 0-40%
(A) CHOICE OF DRUG CANDIDATE
No bitter taste or if it is then it should be masked.
Good stability in water and saliva.
Dose should be low as possible up to 40 mg.
It should be partially unionised at the pH of oral cavity.
It should have the ability to permeate the oral mucosal tissue
Examples of some drugs that can be incorporated in Oral Fast dissolving films are listed in
Table 2.
Fig. 2: Drug Candidate
www.wjpps.com Vol 4, Issue 03, 2015.
349
Varsha et al. World Journal of Pharmacy and Pharmaceutical Sciences
Table 2: Drugs that can be incorporated in fast dissolving films
API Category Therapeutic Category Dose
Nicotine Smoking cessation 1-15mg
Nitroglycerin derivatives Vasodilator 0.3-0.6mg
Zolmitriptan Anti migraine 2.5mg
Loratidine Anti histaminic 5-10 mg
Omeprazole Proton pump inhibitor 10-20mg
Ketoprofen Anti inflammatory 12.5-25mg
Oxycodone Opoid Anagesic 2.5-10mg
Chlorpheniramine maleate Anti allergic 4mg
Loperamide Antidiarroheal 2mg
Triplolidine hydrochloride Antihistaminic 1.0mg
Famotidine Antacid 10mg
Azatidine maleate Antihistaminic 1.0mg
Sumatriptan succinate Antimigraine 35mg
Ketoprofen Analgesic 12.5mg
Cetrizine Antihistaminic 5-10mg
(B) SELECTION OF POLYMER [20, 21]
A variety of polymers are available for preparation of oral dissolving films. The polymers
can be ustilized alone or in combination to enhance hydrophilicity, flexibility, mouth feel
and solubility qualities of oral films.
The stiffness of the film relies on the type of polymer and the amount of polymer in the
formulation.
The different polymers which can be utilized for making mouth dissolving films must be
water soluble with low molecular weight and incredible film forming capacity, since the
primary use of all thin film oral dosage forms relies on their disintegration in the saliva of
the oral cavity.
The polymer employed should be non-toxic, non-irritant with good wetting and
spreadability property.
The polymer should not be very expensive and should be readily available.
Water dissolvable polymer that may be used include natural gums such as xanthan, guar,
acacia, tragacanth other available polymers include cellulose or cellulose derivatives,
hydroxypropylmethyl cellulose with different grades like HPMC E15, HPMC E5, HPMC
K4M, HPMC K100, hydroxyethylcellulose, hydroxypropylcelluose,
carboxymethylcellulose, polyvinylpyrrolidone, polyvinyl alcohol, pullulan, gelatin.
www.wjpps.com Vol 4, Issue 03, 2015.
350
Varsha et al. World Journal of Pharmacy and Pharmaceutical Sciences
The physicochemical characteristic of the polymer or polymers selected for film
formulation play a vital role in determining the resultant disintegration time of the cast
thin film oral dosage form.
Presently, both natural and synthetic polymers are used for preparation of fast dissolving
oral film. Table 3 represents different natural & synthetic polymers which are nowadays
used in Oral Fast preparation.
Table: 3 Polymers Available Preparation of Oral Film [22]
Sr. No. Polymer Examples
1. Natural Polymer Pullulan, Starch, Gelatin, Pectin,Sodium
alginate,Maltodextrins,Polymerized Rosin
2. Synthetic Polymer Hydroxy propyl methyl cellulose, Sodium
Carboxy methyl cellulose, ethylene oxide,
Hydroxy propyl cellulose, Poly vinyl pyrrolidone,
Polyvinyl alcohol
(C)PLASTICIZER [23, 24]
Plasticizer is a key ingredient of the quick dissolving films.
Plasticizer serves to enhance the flexibility of the strip and reduces the brittleness of the
films.
It significantly enhances the film forming properties by diminishing the glass transition
temperature of the polymer.
The chemical structure and concentration of plasticizers play an important role in
alleviating the glass transition temperature of the polymers.
The selection of plasticizer will rely on its compatibility with the polymer and also the
type of solvent employed in the casting of the film.
The flow of polymer will get better with the use of plasticizer and improves the strength
of the polymer. Glycerol, Propylene glycol, low molecular weight polyethylene glycols,
phthalate derivatives like dimethyl, diethyl and dibutyl phthalate, citrate derivatives such
as tributyl, triethyl, acetyl citrate, triacetin and castor oil are some of the regularly utilized
plasticizer excipients.
Typically the plasticizers are used in the concentration of 0–20 percent; w/w of dry
polymer weight. However, inappropriate use of plasticizer may prompt to film breaking,
splitting and peeling of the strip.
It is also reported that the use of certain plasticizers may also affect the absorption rate of
the drug.
www.wjpps.com Vol 4, Issue 03, 2015.
351
Varsha et al. World Journal of Pharmacy and Pharmaceutical Sciences
(D)SWEETENING AGENT [25]
Sweeteners have become the important part of pharmaceutical products intended to be
disintegrated or dissolved in the oral cavity.
The classical source of sweetener is sucrose, dextrose, fructose, glucose, liquid glucose
and isomaltose.
Polyhydric alcohols such as sorbitol, mannitol and isomalt can be utilized as a part of mix
as they mouth feel and cooling sensation.
The artificial sweeteners like Saccharin, cyclamate and aspartame are the first generation
of the artificial sweeteners followed by acesulfame-k, sucralose, alitame and neotame
which fall under the second generation artificial sweeteners.
Generally sweeteners are used in the concentration of 3 to 6 %w/w either alone or in
combination
(E)FLAVOURING AGENT [26]
Ideally up to 10%w/w flavors are added in the Fast dissolving film formulations.
The acceptance of the oral disintegrating or dissolving formulation by an individual is
largely.
Depends on the initial flavor quality which is seen in first few seconds after the product
has been consumed and the after taste of the formulation which lasts for at least about 10
min.
The geriatric population like mint or orange flavors while younger generation like flavors
like fruit punch, raspberry etc.
Flavoring agents can be selected from the synthetic flavor oils, oleo resins, extracts
derived from various parts of plants like leaves, fruits and flowers. Any flavor can be
added such as essential oils or water soluble extracts of menthol, intense mints such as
peppermint, sweet mint, spearmint, wintergreen, cinnamon, clove, sour fruit flavor such
as lemon, orange or sweet confectionary.
Flavors such as vanillin, chocolate or fruit essence like apple, raspberry, cherry,
pineapple.
(F) COLOURING AGENT
A full range of colors is available including FD&C colors, EU colors, natural coloring agents
and natural juice concentrates, pigments such as titanium dioxide, silicon dioxide and zinc
oxide and custom pantone matched colors.
www.wjpps.com Vol 4, Issue 03, 2015.
352
Varsha et al. World Journal of Pharmacy and Pharmaceutical Sciences
MANUFACTURING METHODS [27, 28]
There are five methods for manufacturing purpose:
Solvent casting method
Semisolid casting method
Hot melt extrusion method
Solid dispersion extrusion method
Rolling method
But the most commonly used industrial methods are Solvent-casting method and Hot melt
extrusion.
1. Solvent casting method
Fast dissolving films are ideally formulated using the solvent casting method, whereby the
water soluble ingredients are dissolved to form a clear viscous solution and the drug along
with different excipients is dissolved in a suitable solvent then both the solutions are mixed
and stirred and lastly casted into the Petri plate and dried.
Water soluble ingredients are dissolved in water
API and other agents are dissolved in suitable solvent to form a clear viscous solution
Both the solutions are mixed
Degassed under vacuum
Resulting solution is cast as a film
Film is dried in drying oven and collected
www.wjpps.com Vol 4, Issue 03, 2015.
353
Varsha et al. World Journal of Pharmacy and Pharmaceutical Sciences
Fig. 3: Solvent casting method
2. Hot melt extrusion
Hot melt extrusion method has various benefits; those are fewer operation units, minimum
product wastage, better content uniformity, an anhydrous process, absence of organic
solvents.
In hot melt extrusion method-
Drug is mixed with carriers in solid form.
The extruder having heaters melts the mixture
Finally the melt is shaped in films by the dies
Fig. 4: Hot melt extrusion process
www.wjpps.com Vol 4, Issue 03, 2015.
354
Varsha et al. World Journal of Pharmacy and Pharmaceutical Sciences
3. Semisolid casting method
This technique is ideally embraced when acid insoluble polymers are to be used in the
preparation of the films. Acid-insoluble polymers used to prepare films include: cellulose
acetate phthalate, cellulose acetate butyrate. Acid insoluble polymer and film forming
polymer should be used in the ratio of 1:4.
Solution of water soluble film forming polymer is prepared.
Resulting solution is added to a solution of acid insoluble polymer
Appropriate amount of plasticizer is added so that gels mass is obtained.
Finally the gel mass is casted into the films or ribbons using heat controlled drums.
4. Solid dispersion extrusion method
The term solid dispersions refer to the dispersion of one or more active ingredients in an inert
carrier in a solid state in the presence of amorphous hydrophilic polymers.
Drug is dissolved in a suitable liquid solvent.
Then solution is incorporated into melt of polyethylene glycol, obtainable below 700C.
Finally the solid dispersions are shaped into the films by means of dies.
Precautions while preparing solid dispersions
The selected solvent or dissolved drug may not be miscible with the melt of polyethylene
glycol and polymeric form of drug precipitated in the solid dispersions may get affected by
the liquid solvent used.
5. Rolling method
In this method the film is prepared by preparation of a pre-mix, the addition of an active and
subsequent formation of a film.
www.wjpps.com Vol 4, Issue 03, 2015.
355
Varsha et al. World Journal of Pharmacy and Pharmaceutical Sciences
Prepare pre-mix with film forming polymer, polar solvent and other additives except a drug.
Add pre mix to master batch feed tank.
Fed it via a 1st metering pump and control valve to either or both of the 1st and 2nd mixer.
Add required amount of drug to the desired mixer.
Blend the drug with master batch pre mix to give a uniform matrix.
Then a specific amount of uniform matrix is then fed to the pan through 2nd metering pumps.
The film is finally formed on the substrate and carried away via the support roller.
The wet film is then dried using controlled bottom drying
PACKAGING [29]
In the pharmaceutical industry, it is vital that the package selected adequately should preserve
the integrity of the product. Expensive packaging, specific processing and special care are
required during manufacturing and storage to protect the dosage of other fast dissolving
dosage forms. A variety of packaging options are available for fast dissolving films. Single
packaging is mandatory for films. An aluminum pouch is the most commonly used packaging
format.
1. Foil, paper or plastic pouches
The flexible pouch is a packaging concept capable of providing not only a package that is
temper-resistance, but also by the proper selection of material, a package with a high degree
of environmental protection. A flexible pouch is usually formed during the product filling
operation by either vertical or horizontal forming, filling or sealing equipment. The pouches
can be single pouches or aluminum pouches.
2. Single pouch and Aluminum pouch
Soluble film drug delivery pouch is a able pouch for “quick dissolve” soluble films with high
barrier properties. The pouch is transparent for product display. Using a 2 structure
www.wjpps.com Vol 4, Issue 03, 2015.
356
Varsha et al. World Journal of Pharmacy and Pharmaceutical Sciences
combination allows for one side to be clear and the other to use a cost effective foil
lamination. The foil lamination has essentially zero transmission of both gas and moisture.
The package provides a flexible thin film alternative for nutraceutical and pharmaceutical
application. The single dose pouch provides both product and dosage protection. Aluminum
pouch is the most commonly used pouch.
3. Blister card with multiple units
The blister container consists of two components : the blister, which is the formed cavity that
holds the product, and the lid stock, which is the material that seals to the blister. The blister
package is formed by heat-softening a sheet of thermoplastic resin and vacuum- drawing the
softened sheet of plastic into a contoured mold. After cooling the sheet is released from the
mold and proceeds to the filling station of the packaging machine. The semi rigid blister
previously formed is filled with the product and lidded with the heat sealable backing
material. The film selection should be based upon the degree of protection required.
Generally the lid stock is made of aluminum foil. The material used to form the cavity is
typically a plastic, which can be designed to protect the dosage form from moisture.
EVALUATION TESTS [32, 33, 34, 35, 36, 37, 38, 39]
1. Thickness
As the thickness of film is directly concern with drug content uniformity so it is necessary to
ascertain uniformity in the thickness of the film. It can be measured by micrometer screw
gauge or calibrated digital Vernier Calipers at different strategic locations.
2. Weight Variation
Weight variation is studied by individually weighing 10 randomly selected films and by
calculating the average weight.
3. Folding endurance [30,31]
Folding endurance is determined by repeated folding of the strip at the same place till the
strip breaks. The number of times the film is folded without breaking is computed as the
folding endurance value.
4. Dryness test/tack tests
Tack is the tenacity with which the strip adheres to an accessory (a piece of paper) that has
been pressed into contact with the strip. Instruments are also available for this study.
www.wjpps.com Vol 4, Issue 03, 2015.
357
Varsha et al. World Journal of Pharmacy and Pharmaceutical Sciences
5. Tensile strength
Tensile strength is the maximum stress applied to a point at which the strip specimen breaks.
It is calculated by the applied load at rupture divided by the cross‐sectional area of the strip as
given in the equation below.
Tensile strength = Load at Failure × 100
Strip thickness × Strip Width
6. Percent elongation
When stress is applied, a strip sample stretches and this is referred to as strain. Strain is
basically the deformation of strip divided by original dimension of the sample. Generally
elongation of strip increases as the plasticizer content increases.
% Elongation = Increase in length × 100
Original length
7. Surface pH
The film to be tested was placed in a petri dish and was moistened with 0.5ml of distilled
water and kept for 30sec.The pH was noted after bringing the electrode of the pH meter in
contact with the surface of the formulation and allowing equlibriation for 1min. The average
of three determinations for each formulation was done
8. Uniformity of drug content
This parameter was determined by dissolving one film of dimension 2 x 2cm by
homogenization in 100 ml of stimulated saliva of pH 6.8 for 30 min with continuous shaking.
From this, 10 ml was diluted to 50 ml with simulated salivary fluid. The absorbance was
measured using an UV spectrophotometer. The experiments were carried out in triplicate for
the films of all formulations and average values were recorded.
9. In vitro dissolution studies
Dissolution profile of fast dissolving films was carried out using USP type II (paddle
apparatus) with 300 mL of simulated salivary fluid (pH 6.8) as dissolution medium
maintained at 37 ± 0.50C. Medium was stirred at 100 rpm. Samples were withdrawn at every
30 sec interval, replacing the same amount with the fresh medium. Amount of drug in the
withdrawn samples was determined by UV spectrophotometer. The percent drug released was
plotted against time.
www.wjpps.com Vol 4, Issue 03, 2015.
358
Varsha et al. World Journal of Pharmacy and Pharmaceutical Sciences
10. Disintegration time
Disintegration of orally fast dissolving films requires US disintegration apparatus. The
disintegration time limit of 30 seconds or less for orally disintegrating tablet described in
Centre for Drug Evaluation and Research (CDER) guidance can be applied to fast dissolving
oral strips. Disintegration time will vary depending on the formulation but typically the
disintegration range from 5 to 30 seconds.
CONCLUSION
Sublingual absorption is efficient since the percent of drug absorbed by this route is generally
higher than that achieved by oral route. Sublingual film have gained popularity because of
better patient compliance, rapid onset action, the drug is directly absorbed into systemic
circulation. Films have several advantages over the conventional dosage forms. So, they are
of great importance during the emergency condition like allergy. Short term spasm and
asthma a whenever immediate onset of action is desired. Therefore oral thin films are an
accepted technology for systemic delivery of API’s.
REFERENCE
1. Chowdary YA, Soumya M, Madhu Babu M, Aparna K and Himabindu P. A review of
fast dissolving drug delivery systems- A pioneering drug delivery technology. Bull Env
Pharmacol Life Scien, 2012; 1(12): 08-20.
2. Patil SL, Mahaparale PR, Shivnikar MA, Tiwari SS, Pawar KV and Sane PN. Fast
dissolving oral films: An innovative drug delivery system. Int J Res & Reviews Pharm &
Applied Sci, 2(3): 482-496.
3. Panda B.P, Dey N.S, Rao M.E.B, Development of innovative orally Fast Disintegrating
Film Dosage Forms:A Review. International journal of Pharmaceutical Sciences and
Nanotechnology, 2012; 5(2): 1666-74.
4. Samita Gauri, Gaurav Kumar, Fast Dissolving Drug Delivery and its Technologies. The
Pharma innovation, 2012; 1(2): 34-39.
5. Pandya K, Patel KR, Patel MR and Patel NM. Fast dissolving films: A novel approach to
oral drug delivery. Int J Pharm Teaching & Practices, 2013; 4(2): 655-651.
6. Prajapati V, Bansal M and Sharma PK. Mucoa dhesive buccal patches and use of natural
polymer in its preparation- A review. Int J PharmTech Res, 2012; 4(2): 582-589.
www.wjpps.com Vol 4, Issue 03, 2015.
359
Varsha et al. World Journal of Pharmacy and Pharmaceutical Sciences
7. Nehal Siddiqui MD, Garg G and Sharma PK. A short review on “A novel approach in
oral fast dissolving drug delivery system and their patents”. Advances Bio Res, 2011;
5(6): 291-303.
8. Sarkhejiya NA, Patel VP and Pandya DJ. Sublingual delivery: A promising approach to
improve bioavailability. Pharm Sci Monitor, 2013; 4(2): 3870- 3889.
9. Richman MD, Fox D, Shangraw RF. Preparation and stability of glyceryl trinitrate
sublingual tablets prepared by direct compression. J Pharm Sci, 1965; 54(3): 447‐451
10. McElnay JC, Al‐Furaih TA, Hughes CM, Scott MG, Elborn JS, Nicholls DP. The effect
of pH on the buccal and sublingual absorption of captopril. Eur J Clin Pharmacol, 1995;
48(5): 373‐379.
11. Boer D et al. Drug absorption by sublingual and rectal routes. British J Anesthesia, 1984;
56: 69‐82.
12. Suresh B, Halloran D, James L. Quick dissolving films: A novel approach to drug
delivery. Drug Dev Tech. 2006; 1-7.http://www.drugdeliverytech.com (accessed October,
2012).
13. Arya A, Chandra A. Fast drug delivery systems: A Review. Der Pharmacia Lettre, 2(2):
350-361.
14. Katz M, Barr M. A study of sublingual absorption I. Several factors influencing the rate
of adsorption. J Am Pharm Assoc Am Pharm Assoc (Baltim), 1955; 44(7): 419‐423.
15. Rathbone MJ, Hadgraft J. Absorption of drugs from the human oral cavity , International
Journal Pharm, 1991; 74 :9-24
16. Liang AC, Chen, Li-Lan H. Fast –Dissolving intraoral drug delivery systems, Expert
Opinion, 2001; 11(6): 981-986.
17. ”Oral Thin Films” in Orally Disintegrating Tablet and Film Technologies, 5th
ed.,
Technology Catalysts International Falls Church, V.A, 2008.
18. Rao NR, Reddy SK, Swapna D, Konasree SD and Enugala S. Formulation and evaluation
of rapidly dissolving buccal patches. Int J Pharm & Bio Sci, 2011; 1(3): 145-159
19. Kalyan S and Bansal M. Recent trends in the development of oral dissolving film. Int J
PharmTech Res, 2012; 4(2): 725-733.
20. Kulkarni AS, Deokule HA, Mane MS Ghadge DM. Exploration of different polymers for
use in the formulation of oral fast dissolving strips. J Current Pharm Res, 2010; 2(1): 33-
35.
www.wjpps.com Vol 4, Issue 03, 2015.
360
Varsha et al. World Journal of Pharmacy and Pharmaceutical Sciences
21. Corniello C. Quick dissolving strips: from concept to commercialization. Drug Del
Technol, 2006; 6: 68‐71.
22. Dixit RP, Puthli SP, Oral Strip Technology: Overview and future potential. J. Controlled.
Release, 2009; 139: 94-107.
23. Sakellariou P, Rowe RC. Interactions in cellulose derivative films for oral drug delivery.
Prog Polym Sci, 1995; 20: 889‐942.
24. McIndoe LME, Rowe RC, Sheskey PJ, Owen SC. Handbook of Pharmaceutical
Excipients, Pharmaceutical press. London, 2006: 128‐130.
25. Prakash, DuBois GE, Clos JF, Wilkens KL, Fosdick LE. Development of Rebiana, a
natural, non‐caloric sweetener. Food Chem Toxicol, 2008; 46: 75‐ 82.
26. Barnhart SD. Thin film oral dosage forms in Modified release. Drug Dev Tech, 2007; 1:
34-35.
27. Mahajan A, Chhabra N, Aggarwal G. Formulation and Characterization of Fast
Dissolving Buccal Films: A Review. Scholars Research library Der Pharmacia Lettre,
2011; 3(1): 58-160.
28. Coppens KA, Hall MJ, Mitchell SA. Hypromellose, Ethyl cellulose and Polyethylene
oxide used in hot melt extrusion. Pharmaceutical Technol, 2005; 3:1-6.
29. Ghodake PP, Karande KM, Osmani RA, Bhosale RR, Harkare BR and Kale BB. Mouth
dissolving films: An innovative vehicle oral drug delivery. Int J Pharma Res & Rev.
2013; 2(10): 41-47.
30. Deshmane SV, Joshi UM, Channawar MA, Design and characterization of Carbopol-
HPMC based buccal compact containing Propranolol hydrochloride. Indian Journal of
Pharmaceutical Education and Research, 2010; 44(3): 67-78.
31. Khairnar Amit, Jain Parridhi, Baviskar Rowe Dheeraj, Development of mucoadhesive
buccal patch containing aceclofenac: in vitro evaluation. Internationl Journal of
PharmTech Res,2009; 1(4): 34-42.
32. Subhash Vijaya Kumar, Basanti Gavaskar, Guru Sharan, Madhusudhan Rao Y, Overview
on Fast Dissolving Films. International Journal of Pharmacy and Pharmaceutical
Sciences, 2010; 2(3): 29-33.
33. Patel Nibha K, Pancholi SS, An Overview on Sublingual Route for Systemic Drug
Delivery. International Journal of Research in Pharmaceutical and Biomedical Sciences,
2012; 3(2): 913-23.
www.wjpps.com Vol 4, Issue 03, 2015.
361
Varsha et al. World Journal of Pharmacy and Pharmaceutical Sciences
34. Aggarwal Jyoti. Singh Gurpreet. Saini Seema. Rana A.C, Fast Dissolving Films: A Novel
Approach to Oral Drug Delivery. International Research Journal of Pharmacy, 2011;
2(12): 69-74.
35. Vijaya Sri K, Ravishanker D, Rohini P, Subbarao M, Formulation and In Vitro
Evaluation of Sumatriptan Succinate Oral Thin Films. Indo American Journal of
Pharmaceutical Research, 2013; 3(4): 3016-25.
36. Bhyan Bhupinder, Jangra Sarita, Formulation and evaluation of fast dissolving sublingual
films of Rizatriptan Benzoate. Int. J. Drug Dev. & Res, 2012; 4(1): 133-43.
37. Udhan Ravindra Radhakisan, Vijayalaxmi chavan, NitinTribhuvan, Mouth Dissolving
Film and their Patent: An Overview. Int. Res. J. Pharmacy, 2012; 3(9): 39-42.
38. Rathi Varun, Senthil V, Kammili lavanya, hans Ritu, A Brief Review on Oral Film
Technology. International Journal of Research in Ayurveda and Pharmacy, 2011; 2(4):
1138-47.
39. Vishwkarma D.K, Tripathi A.K, Yogesh P. and Maddheshiya B, Review Article on
Mouth Dissolving Film. Journal of Global Pharma Technology, 2011; 3(1): 1-8.